Abstract
A selective adenosine antagonist (8-cyclopentyl-1,3-dipropylxanthine) eliminates both neuromuscular depression and the action of exogenous adenosine by an effect on A1 receptors.
R S Redman and E M Silinsky
Molecular Pharmacology October 1993, 44 (4) 835-840;